LONG-TERM EVOLUTION OF HOSPITAL RESOURCE UTILIZATION AND ASSOCIATED COSTS USING ADJUSTMENT METHODS: IN PATIENTS TREATED WITH NIVOLUMAB FOR ADVANCED NON-SMALL CELL LUNG CANCER

V Grumberg,C. Chouaid,F. E. Cotte,B. Jouaneton,R. Jolivel,A. F. Gaudin,D. Reynaud,J. B. Assie,I Borget

Value in Health（2022）

引用 0|浏览7

暂无评分

摘要

Few studies explore healthcare resource utilization (HCRU) and their associated costs during the full course of disease. In advanced cancers, HCRU and costs usually increase until end of life. The objective was to describe the evolution of HCRU and costs over 4 years of patients with advanced non-small cell lung cancer (aNSCLC) initiating nivolumab in ≥2nd line.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要